SafeSock

SafeSock exists to close the gap between what clinical science proves and what patients can actually achieve after lower-limb surgery. We built a sensor-lined foot sleeve that delivers real-time haptic biofeedback when patients exceed prescribed weight-bearing limits, turning guesswork into data and data into faster recoveries. With millions Americans undergoing lower-limb procedures annually plus an aging population along with published studies showing 0-2% compliance without monitoring, SafeSock gives patients the confidence and reassurance to recover correctly, surgeons the visibility to prescribe earlier protocols, and hospitals a tool to prevent the $564 million in annual readmission penalties that improper weight-bearing generates.

2.5 million lower-limb orthopedic procedures are performed in the United States every year. Every patient leaves surgery with a weight-bearing prescription. Clinical studies measuring real-world behavior show that 0-2% of patients actually comply with those protocols without real-time feedback. That isn't a patient education problem. It's an infrastructure problem. There is no tool designed for clinical deployment that tells a patient, in the moment, whether they are loading their healing limb correctly. The consequences are measurable. Non-compliance drives preventable complications, surgical failures, and readmissions averaging $8,588-$14,882 per episode. Meanwhile, 20 years of research shows that haptic biofeedback improves weight-bearing compliance by 73%, and that early mobilization with proper monitoring cuts recovery time by 12+ weeks while reducing serious complications by 60%. The clinical evidence is unambiguous. The barrier is monitoring infrastructure. Surgeons understand the evidence. They don't prescribe aggressive early weight-bearing protocols because they have no visibility between office visits. Patients want reassurance and confirmation they are safe to move with a warning when they are not. Both needs point to the same gap: real-time, continuous load monitoring in a form factor that actually works in post-surgical care. That is what SafeSock solves. Every existing competitor like Loadsol, Moticon, Xsensor are insole-based. Insoles are physically incompatible with the surgical boots and walking casts that post-operative patients wear. Those systems cost $5,000+, carry no clinical reimbursement pathway, and were designed for research labs. SafeSock is a sensor-lined sleeve that fits inside any post-surgical footwear, delivers instant haptic feedback when load limits are exceeded, and streams continuous data to surgeon and patient dashboards. Clinical-grade accuracy. Sub-$100 hardware cost. Zero training required. The timing is critical. CMS's TEAM Model, launched January 2026, places 741 hospitals under mandatory bundled payments for lower-extremity procedures, transferring full financial liability for readmissions onto providers. RTM reimbursement codes (CPT 98975/98977/98980) create a direct revenue pathway: orthopedic clinics collect $300-450 per patient episode, more than covering the $300-350 device cost. SafeSock is revenue-neutral to revenue-positive for providers before accounting for complication savings. No competitor has built for this reimbursement architecture. The data advantage compounds with deployment. Each episode generates proprietary recovery trajectory data with a target of 20,000+ patient records by Year 3, a moat no late entrant can replicate without equivalent clinical time in the field. The $25,000 funds the transition to pilot-grade hardware validated for 90 days of real-world use at three committed sites: Johns Hopkins, UNC, and Washington University. That clinical outcomes data drives our FDA 510(k) submission, targeting clearance by Q3 2027 via the remote patient monitoring predicate (SmartStep) pathway. Go-to-market follows the TEAM Model footprint: 741 hospitals already under financial pressure to adopt exactly this solution, reached through clinical advisory relationships already in place.